Cini John K. has filed 3 insider transactions across 1 company since December 2023.
Most recent transaction: a disposition of 14116 shares of Sonnet BioTherapeutics Holdings, Inc. ($SONN) on December 02, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec. 2, 2025 | Sonnet BioTherapeutics Holdings, Inc. | $SONN | Cini John K. | Director | D | Common Stock | 14116 | $0.00 | 0.0000 | 7,077,352 | 100.00% | 0.20% |
| July 11, 2025 | Sonnet BioTherapeutics Holdings, Inc. | $SONN | Cini John K. | Chief Scientific Officer | A | Common Stock | 12000 | $0.00 | 14,116.0000 | 3,332,728 | 567.11% | 0.36% |
| Dec. 11, 2023 | Sonnet BioTherapeutics Holdings, Inc. | $SONN | Cini John K. | Chief Scientific Officer | A | Common Stock | 1888 | $0.00 | 2,116.0000 | 0 | 828.07% | 0.00% |